Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · April 01, 2022

Bisoprolol as Part of a Multimodal Regimen in Hypertrophic Cardiomyopathy

International Journal of Cardiology


Additional Info

International Journal of Cardiology
Bisoprolol for treatment of symptomatic patients with obstructive hypertrophic cardiomyopathy. The BASIC (bisoprolol AS therapy in hypertrophic cardiomyopathy) study
Int J Cardiol 2022 May 01;354(xx)22-28, E Monda, M Lioncino, G Palmiero, F Franco, M Rubino, A Cirillo, F Verrillo, A Fusco, M Caiazza, M Mazzella, E Moscarella, F Dongiglio, J Sepe, G Pacileo, P Calabrò, G Limongelli

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading